PACTR202103700536808招募中未知
Centronuclear myopathy in Southern Africa
niversity College London0 个研究点目标入组 12 人开始时间: 2021年3月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Year(s) 至 12 Year(s)（—）
- 性别
- All
入选标准
- •Children between the ages of 0-18 years
- •Molecular diagnosis of centronuclear myopathy
- •Evidence of decremental activity of greater than 10% on repetitive nerve stimulation testing
排除标准
- •Absence of a genetically confirmed diagnosis of centronuclear myopathy
- •Absence of decremental activity on repetitive nerve stimulation testing
研究者
相似试验
撤回
1 期
Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear MyopathiesCentronuclear MyopathyNCT04743557Dynacure
终止
1 期
Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear MyopathiesCentronuclear MyopathyNCT04033159Dynacure14
招募中
不适用
Outcomes of Proactive Management of Children With MyelomeningoceleUrologic DiseasesNCT06301802Assiut University40
招募中
不适用
ACOP-Trial(Neuralgic Amyotrophy as a cause of Phrenicus-Neuropathy)G54.5Neuralgic amyotrophyDRKS00032586Kliniken der Stadt Köln gGmbH - Lungenklinik (Akademisches lehrkrankenhaus der Universität Witten/Herdecke)80
尚未招募
Unknown
African Critical Illness Outcomes StudyCritical illness - ICU/Critical Care patientsPACTR202307787887272IHR10,000